company background image
HLN logo

Haleon LSE:HLN Stock Report

Last Price

UK£3.21

Market Cap

UK£29.3b

7D

-2.1%

1Y

0.6%

Updated

12 Jun, 2024

Data

Company Financials +

HLN Stock Overview

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HLN fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance2/6
Financial Health3/6
Dividends2/6

Haleon plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Haleon
Historical stock prices
Current Share PriceUK£3.21
52 Week HighUK£3.71
52 Week LowUK£3.07
Beta0
1 Month Change-2.31%
3 Month Change-1.26%
1 Year Change0.60%
3 Year Changen/a
5 Year Changen/a
Change since IPO4.04%

Recent News & Updates

Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 04
Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 04
Haleon plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Haleon plc's (LON:HLN) Popularity With Investors Is Clear

Mar 06
Haleon plc's (LON:HLN) Popularity With Investors Is Clear

Calculating The Intrinsic Value Of Haleon plc (LON:HLN)

Jan 21
Calculating The Intrinsic Value Of Haleon plc (LON:HLN)

Haleon (LON:HLN) Might Have The Makings Of A Multi-Bagger

Nov 24
Haleon (LON:HLN) Might Have The Makings Of A Multi-Bagger

Estimating The Intrinsic Value Of Haleon plc (LON:HLN)

Sep 10
Estimating The Intrinsic Value Of Haleon plc (LON:HLN)

Haleon (LON:HLN) Shareholders Will Want The ROCE Trajectory To Continue

Aug 14
Haleon (LON:HLN) Shareholders Will Want The ROCE Trajectory To Continue

Haleon plc's (LON:HLN) Intrinsic Value Is Potentially 23% Below Its Share Price

May 03
Haleon plc's (LON:HLN) Intrinsic Value Is Potentially 23% Below Its Share Price

Haleon plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 22
Haleon plc Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Can Find Comfort In Haleon's (LON:HLN) Earnings Quality

Mar 10
Investors Can Find Comfort In Haleon's (LON:HLN) Earnings Quality

Calculating The Fair Value Of Haleon plc (LON:HLN)

Dec 18
Calculating The Fair Value Of Haleon plc (LON:HLN)

Shareholder Returns

HLNGB Personal ProductsGB Market
7D-2.1%-0.3%-1.3%
1Y0.6%7.6%4.4%

Return vs Industry: HLN underperformed the UK Personal Products industry which returned 7.6% over the past year.

Return vs Market: HLN underperformed the UK Market which returned 4.4% over the past year.

Price Volatility

Is HLN's price volatile compared to industry and market?
HLN volatility
HLN Average Weekly Movement2.5%
Personal Products Industry Average Movement5.1%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: HLN has not had significant price volatility in the past 3 months.

Volatility Over Time: HLN's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171525,408Brian McNamarawww.haleon.com

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

Haleon plc Fundamentals Summary

How do Haleon's earnings and revenue compare to its market cap?
HLN fundamental statistics
Market capUK£29.32b
Earnings (TTM)UK£1.08b
Revenue (TTM)UK£11.24b

27.1x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HLN income statement (TTM)
RevenueUK£11.24b
Cost of RevenueUK£4.28b
Gross ProfitUK£6.96b
Other ExpensesUK£5.88b
EarningsUK£1.08b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 01, 2024

Earnings per share (EPS)0.12
Gross Margin61.94%
Net Profit Margin9.64%
Debt/Equity Ratio57.4%

How did HLN perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

53%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.